C. Moniz
-
- Bone health and osteoporosis research 3
- Rheumatology top 5%
-
- Bone health and treatments 11
- Pharmacology top 10%
-
- Fibroblast Growth Factor Research 2
- Metabolism, Diabetes, and Cancer 2
-
- Estrogen and related hormone effects 2
-
- Liver Disease Diagnosis and Treatment 2
-
- Vitamin D Research Studies 2
-
- Parathyroid Disorders and Treatments 2
- Co-authors
- Stephan ChristgauPatrick GarneroPer QvistChristian RosenquistÉvelyne GineytsChristian FledeliusPaul BurtonAfshan N. Malik
- Journals
- Bone (2 papers)European Journal of Clinical Investigation (2 papers)Alimentary Pharmacology & Therapeutics (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
C. Moniz
17 papers receiving 636 citations
Peers
Comparison fields: 5 of 81
- Orthopedics and Sports Medicine 148
- Rheumatology 236
- Oncology 224
- Pharmacology 101
- Immunology and Allergy 30
Countries citing papers authored by C. Moniz
This map shows the geographic impact of C. Moniz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Moniz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Moniz more than expected).
Fields of papers citing papers by C. Moniz
This network shows the impact of papers produced by C. Moniz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Moniz. The network helps show where C. Moniz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Moniz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 1 | |
| 2 | 2004 | 35 | |
| 3 | 2001 | 241 | |
| 4 | A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss | 2000 | 25 |
| 5 | A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss. | 2000 | 39 |
| 6 | 1994 | 10 | |
| 7 | 1994 | 31 | |
| 8 | 1994 | 17 | |
| 9 | 1994 | 2 | |
| 10 | 1993 | 8 | |
| 11 | 1993 | 16 | |
| 12 | 1993 | 43 | |
| 13 | 1993 | 26 | |
| 14 | 1992 | 42 | |
| 15 | 1990 | 67 | |
| 16 | 1990 | 17 | |
| 17 | 1989 | 31 |
About C. Moniz
C. Moniz is a scholar working on Oncology, Orthopedics and Sports Medicine, Nephrology, Pharmacy and Immunology and Allergy, having authored 17 papers that have together received 651 indexed citations. Recurring topics across this work include Bone health and treatments (11 papers), Bone health and osteoporosis research (3 papers), Fibroblast Growth Factor Research (2 papers), Estrogen and related hormone effects (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Vitamin D Research Studies (2 papers), Parathyroid Disorders and Treatments (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (148 citations), Rheumatology (236 citations), Oncology (224 citations), Pharmacology (101 citations) and Immunology and Allergy (30 citations). C. Moniz has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Stephan Christgau, Patrick Garnero, Per Qvist, Christian Rosenquist, Évelyne Gineyts, Christian Fledelius, Paul Burton, Afshan N. Malik, D. E. Knight and Philip Quirke. Their work appears in journals such as Bone, European Journal of Clinical Investigation, Alimentary Pharmacology & Therapeutics, Lara D. Veeken and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.